About the journal

Cobiss

Srpski arhiv za celokupno lekarstvo 2005 Volume 133, Issue 11-12, Pages: 484-491
https://doi.org/10.2298/SARH0512484Z
Full text ( 224 KB)
Cited by


Influence of heart failure severity on heart rate variability

Zamaklar-Trifunović Danijela (Institut za kardiovaskularne bolesti, Klinički centar Srbije, Beograd)
Seferović Petar M. (Institut za kardiovaskularne bolesti, Klinički centar Srbije, Beograd)
Živković Mirjana (Institut za kardiovaskularne bolesti, Klinički centar Srbije, Beograd)
Jelić Vera (Univerzitetska dečja klinika, Beograd)
Vukomanović Goran (Institut za kardiovaskularne bolesti, Klinički centar Srbije, Beograd)
Petrović Milan (Institut za medicinsku statistiku, Medicinski fakultet, Beograd)
Milić Nataša (Institut za kardiovaskularne bolesti, Klinički centar Srbije, Beograd)
Ristić Arsen D. ORCID iD icon (Institut za kardiovaskularne bolesti, Klinički centar Srbije, Beograd)
Simeunović Dejan (Institut za kardiovaskularne bolesti, Klinički centar Srbije, Beograd)

Introduction. Autonomic regulation of cardiovascular functions in congestive heart failure is characterised by enhanced sympathetic and diminished parasympathetic activity. The long term predominance of sympathetic tone is a significant factor in arrhythmogenesis, sudden cardiac death, and progressive pump failure. Heart rate variability (HRV) is a noninvasive method for estimating the sympatho vagal balance in cardiovascular control. Aim. The aim of this study was to analyse the influence of heart failure severity on HRV. Method. HRV was estimated through the spectral analysis of short term ECG (Cardiovit AT 60, Schiller, CH) in 63 patients (78% male, mean age 56.9±10.9 years) and 14 healthy volunteers (57.1% male, mean age 53.1±8.2 years). The following spectral components were measured: VLF (very low frequency), LF (low frequency), HF (high frequency), and total power (Tot Power). Results. All spectral components were statistically, significantly lower in patients with heart failure in comparison to healthy controls (VLF: 159.89±147.02 vs. 285.50±202.77 ms2; p=0.023, LF: 161.48±204.01 vs. 474.57±362.93 ms2; p<0.001, HF: 88.58±102.47 vs. 362.71±318.28 ms2; p<0.001), as well as total power (Tot Power: 723.39±644.52 vs. 1807.29±1204.74 ms2; p<0.001). A significant, negative correlation between HRV parameters and NYHA class was detected in heart failure patients (VLF: r=-0.391; p=0.002, LF: r=-0.401; p=0.001, and Tot Power r=-0.372; p=0.003). Ejection fraction proved to be in significant, positive correlation to VLF (r=0.541; p=0.002), LF (r=0.531; p=0.003), HF (r=0.418; p=0.020), and Tot Power (r=0.457; p=0.013). Conclusion. Significant HRV reduction is a precursor to incipient heart failure (NYHA I). In heart failure progression, total power as well as the power of all spectral components is progressively reduced. LF and Tot Power are the most prominent parameters for discriminating between the different stages of heart failure. These results could promote HRV as an important decision-making tool in heart failure treatment as well as in monitoring the results of that treatment.

Keywords: heart failure, heart rate variability, spectral analysis

More data about this article available through SCIndeks